LANDUCCI, ELISA
 Distribuzione geografica
Continente #
EU - Europa 3.438
NA - Nord America 3.150
AS - Asia 465
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.065
Nazione #
US - Stati Uniti d'America 3.142
PL - Polonia 2.305
IT - Italia 326
IE - Irlanda 314
SE - Svezia 248
HK - Hong Kong 159
CN - Cina 146
CH - Svizzera 54
JO - Giordania 52
VN - Vietnam 40
FI - Finlandia 38
TR - Turchia 38
DE - Germania 35
GB - Regno Unito 33
RU - Federazione Russa 29
SG - Singapore 18
UA - Ucraina 18
BE - Belgio 12
FR - Francia 9
CA - Canada 8
ES - Italia 6
IN - India 6
NL - Olanda 5
MU - Mauritius 4
EU - Europa 3
JP - Giappone 3
EG - Egitto 2
HU - Ungheria 2
NG - Nigeria 2
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
IR - Iran 1
KR - Corea 1
NO - Norvegia 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 7.065
Città #
Warsaw 2.304
Fairfield 504
Chandler 321
Dublin 310
Ashburn 267
Woodbridge 243
Seattle 219
Cambridge 191
Wilmington 178
Houston 174
Ann Arbor 145
Hong Kong 100
Florence 93
Lawrence 87
Altamura 85
Beijing 83
Princeton 72
Bern 52
Buffalo 43
Boston 42
Dearborn 42
San Diego 37
Dong Ket 36
Medford 35
Shanghai 33
Boardman 27
Moscow 26
Phoenix 21
Jacksonville 18
Falls Church 17
Brussels 12
Rome 12
New York 10
Hillsboro 9
London 9
Norwalk 9
Turin 9
Milan 8
Singapore 8
Izmir 7
Naples 7
Redmond 7
West Jordan 6
Toronto 5
Andover 4
Barcelona 4
Bremen 4
Laurel 4
Los Angeles 4
Nanjing 4
Paris 4
Redwood City 4
Castelliri 3
Chennai 3
Ferrara 3
Hefei 3
Kent 3
Lappeenranta 3
Ottawa 3
Pescara 3
Washington 3
Agliana 2
Bologna 2
Böblingen 2
Cagliari 2
Cascina 2
Gallarate 2
Giza 2
Gorgonzola 2
Guangzhou 2
Hangzhou 2
Jinan 2
Livorno 2
Massa 2
Naaldwijk 2
Nagold 2
Napoli 2
Ningbo 2
Pisa 2
Pune 2
Sassuolo 2
Seriate 2
Sermoneta 2
Tokyo 2
Avellino 1
Bloomington 1
Bovisio Masciago 1
Brentford 1
Campi Bisenzio 1
Changsha 1
Chengdu 1
Collecchio 1
Dallas 1
Elkins Park 1
Ergolding 1
Fiesole 1
Frankfurt (Oder) 1
Frankfurt am Main 1
Fuzhou 1
Garbagnate Milanese 1
Totale 6.044
Nome #
Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism 251
3-Iodothyroacetic acid (TA1), a by-product of thyroid hormone metabolism, reduces the hypnotic effect of ethanol without interacting at GABA-A receptors. 231
The pro-healing effect of exendin-4 on wounds produced by abrasion in normoglycemic mice 224
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 223
In the brain of mice,3-iodothyronamine(T1AM) is converted into 3-iodothyroaceticacid(TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine 222
Arrays of MicroLEDs and Astrocytes: Biological Amplifiers to Optogenetically Modulate Neuronal Networks Reducing Light Requirement 215
Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance 211
Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold 205
Glutamate receptor and transporter modifications in rat organotypic hippocampal slice cultures exposed to oxygen-glucose deprivation: The contribution of cyclooxygenase-2 202
Interplay between histone acetylation/deacetylation and poly(ADPribosyl)ation in the development of ischemic tolerance in vitro 198
Anticonvulsant and Neuroprotective Effects of the Thyroid Hormone Metabolite 3-Iodothyroacetic Acid. 194
Neuroprotective effects of topiramate and memantine in combination with hypothermia in hypoxic-ischemic brain injury in vitro and in vivo 193
Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability 189
The gliadin peptide 31-43 exacerbates kainate neurotoxicity in epilepsy models 178
Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. 158
Brain histamine modulates the antidepressant-like effect of the 3-iodothyroacetic acid (TA1) 158
Bicuculline Reverts the Neuroprotective Effects of Meloxicam in an Oxygen and Glucose Deprivation (OGD) Model of Organotypic Hippocampal Slice Cultures 150
Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases. 147
Thyroid Hormone, Thyroid Hormone Metabolites and Mast Cells: A Less Explored Issue. 147
Glutamate Receptor-Mediated Neurotoxicity in a Model of Ethanol Dependence and Withdrawal in Rat Organotypic Hippocampal Slice Cultures 141
Formulation of Nanomicelles to Improve the Solubility and the Oral Absorption of Silymarin 135
Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors 134
Using organotypic hippocampal slice cultures to gain insight into mechanisms responsible for the neuroprotective effects of meloxicam: A role for gamma aminobutyric and endoplasmic reticulum stress 126
Niosomal Formulation of a Lipoyl-Carnosine Derivative Targeting TRPA1 Channels in Brain 125
N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity 123
Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery 112
A new ophthalmic formulation containing antiseptics and dexpanthenol: In vitro antimicrobial activity and effects on corneal and conjunctival epithelial cells 104
Rat hippocampal slice culture models for the evaluation of neuroprotective agents. 103
PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca2+-permeable AMPA receptors 101
Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K–Akt signaling pathway: A novel postconditioning strategy? 91
Enhanced Neuroprotective Effects of Panax Ginseng G115® and Ginkgo Biloba GK501® Combinations In Vitro Models of Excitotoxicity 88
Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance 85
3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes. 84
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study 82
Ethanol Toxicity During Brain Development: Alterations of Excitatory Synaptic Transmission in Immature Organotypic Hippocampal Slice Cultures 81
BRAIN-TARGETED DELIVERY OF ANDROGRAPHOLIDE USING SOLID LIPID NANOPARTICLES: IN VITRO AND IN VIVO EVALUATION 80
CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices 78
Tolerance Induced by (S)-3,5-Dihydroxyphenylglycine Postconditioning is Mediated by the PI3K/Akt/GSK3β Signalling Pathway in an In Vitro Model of Cerebral Ischemia 71
Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization 70
Neurotoxicity of Unconjugated Bilirubin in Mature and Immature Rat Organotypic Hippocampal Slice Cultures 69
Differential mechanisms of tolerance induced by NMDA and DHPG preconditioning 69
Enhanced dissolution, permeation and oral bioavailability of aripiprazole mixed micelles: In vitro and in vivo evaluation 62
Antiseptics and the Ocular Surface: In Vitro Antimicrobial Activity and Effects on Conjunctival and Corneal Epithelial Cells of a New Liposomal Ocular Spray Containing Biosecur Citrus Extract 59
Preconditioning with NMDA, but not DHPG, induces tolerance to excitotoxicity by internalization of AMPA receptors. 56
Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva 54
Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia 52
Preconditioning With NMDA and DHPG Induces Ischemic Tolerance With Differential Mechanisms In An In Vitro Hippocampal Slice Model Of Excitotoxicity 51
Applications of innovative technologies to the antipsychotics delivery. 49
Nerve Growth Factor mimetics with neuroprotective activity in ischemic brain damage 48
Interplay between group I mGlu and the endocannabinoid system in the hippocampus: studies in models of cerebral ischemia 48
mGlu1 receptors and endocannabinoids: neuroprotection studies in an in vitro model of cerebral ischemia 47
DHPG and NMDA preconditioning induce ischemic tolerance with differential mechanisms 45
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: studies in models of cerebral ischemia 42
Mild activation of ionotropic and metabotropic glutamate receptors induces ischemic tolerance with differential mechanisms in rat organotypic hippocampal slices 42
Neuroprotective effects of cannabidiol but not Δ9-tetrahydrocannabinol in rat hippocampal slices exposed to oxygen-glucose deprivation: studies with Cannabis extracts and selected cannabinoids. 40
Endocannabinoids play a crucial role in the mechanisms of mGlu1-mediated neuroprotection in models of cerebral ischemia. 39
Neuroprotective effects of thymoquinone by the modulation of ER stress and apoptotic pathway in in vitro model of excitotoxicity. 39
Nerve growth factor (NGF) mimetics modulate ischemic brain damage 38
Improved super-bright microLEDs for bi-dimensional optogenetic applications and opto-electronic retinal prosthesis. 38
MPP+-dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons 38
An electrophysiological study of the mGlu1 receptors ability to modulate endocannabinoids production and inhibitory synaptic transmission in the CA1 hippocampal area 38
Preconditioning with NMDA and DHPG induces ischemic tolerance with differential mechanisms in an in vitro hippocampal slice model 37
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: an electrophysiological study 36
Preparation of liposomal formulations for ocular delivery of thymoquinone: in vitro evaluation in HCEC-2 e HConEC cells. 36
Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model 33
NMDA and DHPG preconditioning induce ischemic tolerance with differential mechanisms in rat organotypic hippocampal slices 33
Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: in vitro test and in vivo toxicity assessment in Zebrafish embryos. 33
Neuroprotection following postconditioning via group I mGlu receptor activation is coupled to the PI3K/Akt/GSK3β signalling pathway in a rat organotypic hippocampal slice model of cerebral ischemia 28
Interplay between mGlu1 and CB1 receptors in the postischemic CA1 hippocampal area: Neuroprotection and anatomical studies. 27
Evaluation of Conventional and Hyaluronic Acid-Coated Thymoquinone Liposomes in an In Vitro Model of Dry Eye 24
Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol 23
The Neuroprotective Effects of mGlu1 Receptor Antagonists Are Mediated by an Enhancement of GABAergic Synaptic Transmission via a Presynaptic CB1 Receptor Mechanism 21
Virtual screening and in vitro experiments highlight cannabidiol as a drug-like phosphodiesterase 9 inhibitor 19
Cannabidiol preferentially binds TRPV2: a novel mechanism of action 19
The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation 18
Experimental Models for Testing the Efficacy of Pharmacological Treatments for Neonatal Hypoxic-Ischemic Encephalopathy 10
Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model 8
Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases 4
Anti-Inflammatory Properties of Cannabidiol and Beta-Caryophyllene Alone or Combined in an In Vitro Inflammation Model 1
Totale 7.183
Categoria #
all - tutte 19.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.356


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019338 0 0 0 0 0 0 0 0 0 0 191 147
2019/20201.865 118 165 60 126 223 203 213 222 175 157 170 33
2020/20211.264 108 148 37 149 105 106 71 90 121 211 54 64
2021/2022514 17 29 34 18 14 47 35 35 29 32 88 136
2022/20231.514 116 264 82 84 107 249 192 90 197 14 49 70
2023/2024574 19 76 88 24 60 68 36 143 17 33 10 0
Totale 7.183